News

The double-blinded, placebo-controlled phase II clinical study was designed to evaluate the safety and efficacy of COL-3 for the treatment of rosacea, an inflammatory skin condition. At all

Memory and Roche entered into a collaboration for the development of PDE4 inhibitors for psychiatric and neurological indications in 2002. Roche has now decided not to pursue further

Peregrine Pharmaceuticals today announced that a paper titled “NHS76/PEP2, a Fully Human Vasopermeability-Enhancing Agent to Increase the Uptake and Efficacy of Cancer Chemotherapy,” The paper, which was published

Safety and immune response data were presented from the first of several ongoing phase I clinical trials involving the HIV vaccine candidate at a Keystone Symposium in Alberta,

Over the course of 18 years, 30 children aged 18 years and younger were treated with tetrabenazine at Columbia University Medical Center for a variety of hyperkinetic movement

This phase IIb study is an international, multicenter, open label, randomized, controlled clinical trial to evaluate the safety and efficacy of treatment with CoFactor plus 5-fluorouracil (5-FU) in

The National Cancer Institute-sponsored trial was designed to evaluate Avastin (bevacizumab) plus paclitaxel chemotherapy in first-line metastatic breast cancer, with the primary endpoint being an improvement in progression-free

The follow-up study, named 16-LTF, provides clinical assessment of patients who first enrolled in the Betaseron (interferon beta-1b) pivotal trial between 1988 and 1990. The results of the

The data were presented at the 40th annual meeting of the European Association for the Study of the Liver (EASL) in Paris, France. The phase II clinical trial,